GLP-1

8 statements across 7 episodes · 3 bullish · 2 bearish · 5 people on the record · first statement Nov 19, 2024 by Jordi Hays · said 1 times in 1 episodes since 2025 · across every show →

Mentions by year

brought up most by Bryan Johnson (1)

tap a year for its mentions
0011112025episodesmentions
0112025episodes it came up in
000.50.5112025episodesmentions per episode

every mention, scene by scene, with the transcript →

Everything said about GLP-1, oldest first

Nov 19, 2024 neutral
Assertion Partly supported
Hays: Nobody makes generic exenatide because it requires twice-daily doses
“The one X, Xenotide, Xenotide, which was the first one, the patents are expired, and nobody's even bothered to make it generic, because you have to take it twice a day.”
Jordi Hays Nov 19, 2024 ▶ 59:50 Who's Getting Rich Off Ozempic? (e12)
Jun 14, 2025 positive
Opinion
Huberman: GLP-1 drugs ended the debate on the cause of obesity
“This peptide acts at the level of the brain and the gut to make people feel more full. It also, by the way, shut down the debate as to why people are fat. It's because they eat too much. Right? They eat more than they burn. Remember people used to argue about …”
Andrew Huberman Jun 14, 2025 ▶ 1:17:43 Weekly Recap: Apple WWDC, Andrew Huberman, YC Demo Day, Intern Phone Assembly, $14B Meta x Scale
Jun 26, 2025 negative
Opinion
Huberman: Peptides should not be relegated to gray-market gym testing
“It's my opinion that every single peptide, not just GLP-I, every single peptide shouldn't be getting tested in the gray market of, like, gyms and, like, biohacking. That's, frankly, that's bullshit.”
Andrew Huberman Jun 26, 2025 ▶ 12:54 Andrew Huberman on the Uncertain Future of Science
Jun 26, 2025
Opinion
Huberman: GLP-1 proved people become fat because they eat too much
“It also, by the way, shut down the debate as to why people are fat. It's because they eat too much.”
Andrew Huberman Jun 26, 2025 ▶ 10:44 Andrew Huberman on the Uncertain Future of Science
Oct 30, 2025 bullish
Disclosure
Johnson: Blueprint will offer GLP-1 prescriptions and telemedicine infrastructure
“We will build an infrastructure to basically, when you want a prescription, if you want to go on a GLP-ONE, we can help you get started. Whether you want a large dose or a micro dose,”
Bryan Johnson Oct 30, 2025 ▶ 11:49 Don't Die CEO Bryan Johnson on Living Forever, AI & His $60M Blueprint For Immortality
Mar 23, 2026 bullish
Prediction Not checkable as stated
Marchione: Under-researched peptide classes might change the world
“And we've seen one category of peptides GLP-ONE's already changed the world, and my contention is that there are other categories of peptides that are under-researched, but have really interesting kind of clinical vignettes that might change the world going fo…”
Max Marchione Mar 23, 2026 ▶ 4:54 The Great Peptide Debate with Martin Shkreli & Max Marchione
Apr 6, 2026 negative
Assertion Supported
Coogan: MedV runs 800 fake doctor Facebook accounts to sell GLP-1s
“They are apparently running 800 fake doctor accounts on Facebook to sell compounded GLP ones. Shiel Monat verified that the accounts are not actually doctors.”
John Coogan Apr 6, 2026 ▶ 10:51 The Truth Behind the “Solo Founder Billion Dollar Company”
Aug 8, 2026 neutral
Insight
Biotech must rebrand viruses for gene therapy treatments to succeed
“If we're going to get advances in viruses that deliver gene therapies or medical treatments, we got to rebrand virus. We got to come up with a new word, just like GLP one peptide that felt very safe.”
John Coogan Aug 8, 2026 ▶ 5:19 AI-Designed Viruses, OpenAI’s First Device, The Mansion Section | Diet TBPN
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 500 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.